Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by Pj1958on Jun 04, 2016 5:45pm
79 Views
Post# 24934708

RE:RE:RE:Jason Mann past picks are his idea of "investable"

RE:RE:RE:Jason Mann past picks are his idea of "investable"LETTUCE...Total hogwash... Another scare tactic about cashflow.
You shorts will make up any excuse. MT has shown you CF in Q1. What the hell
are you doing on this BB if you have no investment in CXR , that's like a faggot in a stripper bar.
And if you are invested in CXR , then you are a moron.






Lattice wrote:
TickerTwit wrote:
Roller007 wrote: So Cxr is not investable but two his last three investable top picks are down 25% each.  And his third was shorting teck resources at $12 where he covered around $9 but the stock went to $3.  This loser is another bnn genius.  

It is better to focus on the reason Mann gave for it being "uninvestable": the swings. Another way to say it is, 'Not behaving on fundamentals, therefore it's only fit for speculating and not for investing.'

Analyze his reason, not his past performance (which is irrelevant).

This concludes the logic lesson for today..


Jason Mann Verbatim:    2016-06-03  "The challenge is, if there is a deal you could see this in the mid to high $40s, but if there is no deal, they have a lot of debt and it is a very volatile stock and not generatng the kind of earnings that support the cash flow for their debt."

Bang on.  The adjusted eps that all these drug companies pitch is nothing more than spinning straw into gold.  The balance sheet is boned and the chickens are happily roosting.


<< Previous
Bullboard Posts
Next >>